Back to search

Article

DEPRESSION AND ANXIETY SYMPTOMS FOLLOWING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN ADULTS WITH CYSTIC FIBROSIS

2022-12-23

Abstract excerpt

<h4>Background: </h4> Elexacaftor/tezacaftor/ivacaftor (E/T/I), has broadened access to life-changing pharmacotherapy for people living with cystic fibrosis (plwCF). However, case reports suggest CFTR modulators may induce psychiatric adverse symptoms. To systematically examine this, we studied depression and anxiety symptoms before and after initiation of E/T/I. <h4>Methods: </h4>: Patient Health Questionnaire-9...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b039a4a8-9601-5b33-96ab-7d01797d992f
DOI
10.22541/au.167180415.52519057/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DEPRESSION AND ANXIETY SYMPTOMS FOLLOWING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN ADULTS WITH CYSTIC FIBROSISDOI 10.22541/au.167180415.52519057/v1
Select a neighboring publication to make it the new centre.